Biden administration to retire 'Operation Warp Speed' name
January 15, 2021 -- The incoming Biden administration said that it will no longer use the "Operation Warp Speed" term to describe the U.S. government's efforts to combat the COVID-19 pandemic.
Precision Medicine acquires Project Farma
January 15, 2021 -- Precision Medicine has acquired Project Farma, a bioengineering services firm.
Thermo Fisher closes Henogen acquisition
January 15, 2021 -- Thermo Fisher Scientific has closed its acquisition of Groupe Novasep's Henogen, a viral vector manufacturing business in Belgium, for approximately 725 million euros ($876 million U.S.) in cash.
Gamma Biosciences to acquire BioMagnetic Solutions
January 15, 2021 -- Gamma Biosciences has agreed to acquire BioMagnetic Solutions, a next-generation cell selection and bioseparation technology company.
Cognate BioServices expands manufacturing in U.S., Europe
January 15, 2021 -- Contract development and manufacturing organization Cognate BioServices plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and to increase office support at its facilities in the U.S. and Europe.
RoosterBio, Sartorius partner on cell and gene therapy manufacturing
January 15, 2021 -- RoosterBio and Sartorius have signed a strategic collaboration to advance the scale-up of human mesenchymal stem/stromal cells manufacturing for regenerative medicines.
Nucleai and Debiopharm team up in AI-based cancer drug development
January 14, 2021 -- Biomarker discovery company Nucleai will be working with Swiss pharmaceutical developer Debiopharm to optimize development of a clinical oncology asset per a new research collaboration.
Fujifilm secures funding, signs lease for new research/manufacturing center
January 14, 2021 -- Fujifilm Diosynth Biotechnologies has announced $76 million in financing for the Center for Advanced Biological Innovation and Manufacturing and that a lease for a site in the Boston area has been signed.
Startup Creative Bio launches cell culture portfolio
January 14, 2021 -- Creative Bio has launched a portfolio of cell culture tools that it hopes will be useful during the COVID-19 pandemic.
Bone Therapeutics, Rigenerand partner on cell therapy process development
January 14, 2021 -- Bone Therapeutics and Rigenerand have formed a cell therapy process development partnership.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter